{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:41:04Z","timestamp":1778910064648,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00404-017-4639-7","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T22:58:48Z","timestamp":1514501928000},"page":"467-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis"],"prefix":"10.1007","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-1914","authenticated-orcid":false,"given":"Fei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"issue":"2","key":"4639_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4639_CR2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.humpath.2011.05.021","volume":"43","author":"S Yeasmin","year":"2012","unstructured":"Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K et al (2012) Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas\/adenosquamous carcinomas. Hum Pathol 43(4):506\u2013519","journal-title":"Hum Pathol"},{"issue":"5","key":"4639_CR3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1134\/S0006297908050027","volume":"73","author":"H zur Hausen","year":"2008","unstructured":"zur Hausen H (2008) Papillomaviruses\u2014to vaccination and beyond. Biochemistry (Mosc) 73(5):498\u2013503","journal-title":"Biochemistry (Mosc)"},{"issue":"14","key":"4639_CR4","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB et al (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97(14):1072\u20131079","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"4639_CR5","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1200\/JCO.2009.25.4151","volume":"28","author":"EA Kidd","year":"2010","unstructured":"Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW (2010) Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol 28(12):2108\u20132113","journal-title":"J Clin Oncol"},{"issue":"17","key":"4639_CR6","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.2001.19.17.3745","volume":"19","author":"PW Grigsby","year":"2001","unstructured":"Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19(17):3745\u20133749","journal-title":"J Clin Oncol"},{"key":"4639_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ebiom.2017.03.038","volume":"18","author":"M Ye","year":"2017","unstructured":"Ye M, Huang T, Ni C, Yang P, Chen S (2017) Diagnostic capacity of RASSF1A promoter methylation as a biomarker in tissue, brushing, and blood samples of nasopharyngeal carcinoma. EBioMedicine 18:32\u201340","journal-title":"EBioMedicine"},{"issue":"4","key":"4639_CR8","doi-asserted-by":"crossref","first-page":"e5956","DOI":"10.1097\/MD.0000000000005956","volume":"96","author":"M Ye","year":"2017","unstructured":"Ye M, Huang T, Li J, Zhou C, Yang P, Ni C, Chen S (2017) Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: a systematic meta-analysis under PRISMA guidelines. Medicine (Baltimore) 96(4):e5956","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"4639_CR9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jnci\/93.9.691","volume":"93","author":"DG Burbee","year":"2001","unstructured":"Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D et al (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93(9):691\u2013699","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"4639_CR10","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1158\/0008-5472.CAN-04-2792","volume":"65","author":"YM Whang","year":"2005","unstructured":"Whang YM, Kim YH, Kim JS, Yoo YD (2005) RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 65(9):3682\u20133690","journal-title":"Cancer Res"},{"issue":"9","key":"4639_CR11","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1158\/0008-5472.CAN-04-4088","volume":"65","author":"A Agathanggelou","year":"2005","unstructured":"Agathanggelou A, Cooper WN, Latif F (2005) Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65(9):3497\u20133508","journal-title":"Cancer Res"},{"issue":"9","key":"4639_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/pin.12332","volume":"65","author":"I Blanco-Luquin","year":"2015","unstructured":"Blanco-Luquin I, Guarch R, Ojer A, Perez-Janices N, Martin-Sanchez E, Maria-Ruiz S, Monreal-Santesteban I et al (2015) Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix. Pathol Int 65(9):476\u2013485","journal-title":"Pathol Int"},{"issue":"5","key":"4639_CR13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10541-005-0151-y","volume":"70","author":"GP Pfeifer","year":"2005","unstructured":"Pfeifer GP, Dammann R (2005) Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc) 70(5):576\u2013583","journal-title":"Biochemistry (Mosc)"},{"issue":"1","key":"4639_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2007.03.015","volume":"255","author":"CH Choi","year":"2007","unstructured":"Choi CH, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ et al (2007) Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett 255(1):26\u201333","journal-title":"Cancer Lett"},{"issue":"4","key":"4639_CR15","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65\u2013W94","journal-title":"Ann Intern Med"},{"issue":"3","key":"4639_CR16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ije\/dyp157","volume":"39","author":"MD Coory","year":"2010","unstructured":"Coory MD (2010) Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 39(3):932 (author reply 933)","journal-title":"Int J Epidemiol"},{"issue":"7414","key":"4639_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"9","key":"4639_CR18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","volume":"127","author":"J Lau","year":"1997","unstructured":"Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820\u2013826","journal-title":"Ann Intern Med"},{"issue":"7109","key":"4639_CR19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"3","key":"4639_CR20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jrsm.1104","volume":"5","author":"E Kulinskaya","year":"2014","unstructured":"Kulinskaya E, Wood J (2014) Trial sequential methods for meta-analysis. Res Synth Methods 5(3):212\u2013220","journal-title":"Res Synth Methods"},{"issue":"8","key":"4639_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J (2008) Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol 61(8):763\u2013769","journal-title":"J Clin Epidemiol"},{"key":"4639_CR22","doi-asserted-by":"crossref","first-page":"h1354","DOI":"10.1136\/bmj.h1354","volume":"350","author":"LB Holst","year":"2015","unstructured":"Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J (2015) Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 350:h1354","journal-title":"BMJ"},{"key":"4639_CR23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C (2009) Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 9:86","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"4639_CR24","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3892\/or.2017.5465","volume":"37","author":"F Yin","year":"2017","unstructured":"Yin F, Wang N, Wang S, Yu F, Sun X, Yu X, Luo B et al (2017) HPV16 oncogenes E6 or\/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Oncol Rep 37(4):2324\u20132334","journal-title":"Oncol Rep"},{"issue":"12","key":"4639_CR25","first-page":"929","volume":"48","author":"H Wang","year":"2013","unstructured":"Wang H, Pan SY, Pang ZR, Wang F, Xu J, Chen D, Xie EF et al (2013) Quantitative detection of APC\/RASSF1A promoter methylation in the plasma of patients with cervical diseases. Zhonghua Fu Chan Ke Za Zhi 48(12):929\u2013934","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"9","key":"4639_CR26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mc.20837","volume":"51","author":"S Mitra","year":"2012","unstructured":"Mitra S, Mazumder Indra D, Basu PS, Mondal RK, Roy A, Roychoudhury S, Panda CK (2012) Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance. Mol Carcinog 51(9):723\u2013733","journal-title":"Mol Carcinog"},{"issue":"1","key":"4639_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2009.09.032","volume":"116","author":"JH Kim","year":"2010","unstructured":"Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C (2010) Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol 116(1):99\u2013104","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4639_CR28","first-page":"76","volume":"95","author":"Z Pan","year":"2009","unstructured":"Pan Z, Li J, Pan X, Chen S, Wang Z, Li F, Qu S et al (2009) Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma. Tumori 95(1):76\u201380","journal-title":"Tumori"},{"issue":"6","key":"4639_CR29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/13547500802078859","volume":"13","author":"MK Neyaz","year":"2008","unstructured":"Neyaz MK, Kumar RS, Hussain S, Naqvi SH, Kohaar I, Thakur N, Kashyap V et al (2008) Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population. Biomarkers 13(6):597\u2013606","journal-title":"Biomarkers"},{"issue":"2","key":"4639_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/epi.2.2.3692","volume":"2","author":"G Gokul","year":"2007","unstructured":"Gokul G, Gautami B, Malathi S, Sowjanya AP, Poli UR, Jain M, Ramakrishna G et al (2007) DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer. Epigenetics 2(2):80\u201385","journal-title":"Epigenetics"},{"issue":"6","key":"4639_CR31","first-page":"394","volume":"42","author":"J Xu","year":"2007","unstructured":"Xu J, Wang HL, Lu GC, Wang ZJ, Lin X, Zhou HW (2007) Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue. Zhonghua Fu Chan Ke Za Zhi 42(6):394\u2013397","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"3","key":"4639_CR32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ygyno.2007.01.045","volume":"105","author":"S Kang","year":"2007","unstructured":"Kang S, Kim HS, Seo SS, Park SY, Sidransky D, Dong SM (2007) Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. Gynecol Oncol 105(3):662\u2013666","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4639_CR33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ygyno.2006.10.003","volume":"104","author":"HC Lai","year":"2007","unstructured":"Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH, Chu TY (2007) Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol 104(3):629\u2013635","journal-title":"Gynecol Oncol"},{"issue":"8","key":"4639_CR34","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/ijc.22060","volume":"119","author":"GB Wisman","year":"2006","unstructured":"Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ et al (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119(8):1908\u20131914","journal-title":"Int J Cancer"},{"issue":"9","key":"4639_CR35","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/ijc.21609","volume":"118","author":"S Kang","year":"2006","unstructured":"Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY et al (2006) Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 118(9):2168\u20132171","journal-title":"Int J Cancer"},{"issue":"6","key":"4639_CR36","first-page":"1005","volume":"38","author":"AV Maliukova","year":"2004","unstructured":"Maliukova AV, Loginov VI, Khodyrev DS, Kadyrova EL, Pronina IV, Ivanova TA, Kiselev FL et al (2004) Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors. Mol Biol (Mosk) 38(6):1005\u20131013","journal-title":"Mol Biol (Mosk)"},{"issue":"1","key":"4639_CR37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2004.09.031","volume":"96","author":"S Kang","year":"2005","unstructured":"Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP (2005) Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96(1):173\u2013180","journal-title":"Gynecol Oncol"},{"issue":"8","key":"4639_CR38","first-page":"2981","volume":"9","author":"Y Cohen","year":"2003","unstructured":"Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D (2003) The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res 9(8):2981\u20132984","journal-title":"Clin Cancer Res"},{"key":"4639_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-2-24","volume":"2","author":"G Narayan","year":"2003","unstructured":"Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A et al (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2:24","journal-title":"Mol Cancer"},{"issue":"8","key":"4639_CR40","first-page":"1888","volume":"63","author":"I Kuzmin","year":"2003","unstructured":"Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI et al (2003) Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res 63(8):1888\u20131893","journal-title":"Cancer Res"},{"issue":"2","key":"4639_CR41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.11051","volume":"105","author":"MY Yu","year":"2003","unstructured":"Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW et al (2003) Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer 105(2):204\u2013209","journal-title":"Int J Cancer"},{"issue":"12","key":"4639_CR42","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.onc.1204175","volume":"20","author":"A Agathanggelou","year":"2001","unstructured":"Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P et al (2001) Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20(12):1509\u20131518","journal-title":"Oncogene"},{"issue":"4","key":"4639_CR43","first-page":"216","volume":"32","author":"JX An","year":"2005","unstructured":"An JX, Yang YX, Wang XH (2005) Detection of promoter hypermethylation of RASSF1A and clinical significance in cervix carcinoma. Cancer Res Prev Treat 32(4):216\u2013219","journal-title":"Cancer Res Prev Treat"},{"issue":"8","key":"4639_CR44","first-page":"611","volume":"20","author":"YH Qiao","year":"2010","unstructured":"Qiao YH, Wang L, Liu HY, Guo RX, Zhang XY, Zhao XL (2010) Methylation and protein expression of RASSF1A gene in cervical squamous cell carcinoma. China Oncol 20(8):611\u2013614","journal-title":"China Oncol"},{"key":"4639_CR45","first-page":"1529","volume":"14","author":"HY Cui","year":"2011","unstructured":"Cui HY, Zhou XR, Han Q (2011) Methylation status of RASSF1A gene promoter in cervical carcinoma and its clinical significance. Chin Gen Pract 14:1529\u20131534","journal-title":"Chin Gen Pract"},{"issue":"12","key":"4639_CR46","first-page":"1518","volume":"10","author":"Q Li","year":"2013","unstructured":"Li Q, Hu CH, Zhang J (2013) Promoter methylation of RASSF1A gene in exfoliated cervical cytology from cervical carcinoma and its clinical application. Lab Med Clinic 10(12):1518\u20131519","journal-title":"Lab Med Clinic"},{"issue":"21","key":"4639_CR47","first-page":"3693","volume":"30","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Z, Yang P (2015) Detection and clinical significance of methylation of plasma RASSF1A gene promoter in Uyghur patients with cervical squamous cell carcinoma. Matern Child Health Care China 30(21):3693\u20133695","journal-title":"Matern Child Health Care China"},{"issue":"2","key":"4639_CR48","first-page":"275","volume":"1865","author":"A Kazanets","year":"2016","unstructured":"Kazanets A, Shorstova T, Hilmi K, Marques M, Witcher M (2016) Epigenetic silencing of tumor suppressor genes: paradigms, puzzles, and potential. Biochim Biophys Acta 1865(2):275\u2013288","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"4639_CR49","doi-asserted-by":"crossref","first-page":"e107272","DOI":"10.1371\/journal.pone.0107272","volume":"9","author":"J Xiong","year":"2014","unstructured":"Xiong J, Li Y, Huang K, Lu M, Shi H, Ma L, Luo A et al (2014) Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis. PLoS One 9(9):e107272","journal-title":"PLoS One"},{"issue":"14","key":"4639_CR50","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.7314\/APJCP.2015.16.14.5749","volume":"16","author":"JY Li","year":"2015","unstructured":"Li JY, Huang T, Zhang C, Jiang DJ, Hong QX, Ji HH, Ye M et al (2015) Association between RASSF1A promoter hypermethylation and oncogenic HPV infection status in invasive cervical cancer: a meta-analysis. Asian Pac J Cancer Prev 16(14):5749\u20135754","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-017-4639-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4639-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4639-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T23:20:53Z","timestamp":1516576853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-017-4639-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4639"],"URL":"https:\/\/doi.org\/10.1007\/s00404-017-4639-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}